Accelerating Genomic Medicine for a Healthier Future

Horizon is your comprehensive variant interpretation platform. Transition from germline and somatic variants to actionable clinical insights: faster, and with precision

Trusted by clinical & research partners worldwide
Canarie
Global Alliance
Memorial University
NVIDIA
Canada Digital Technology Supercluster
NeuroGen Healthcare
Life Span
MBRU
Newcastle University
The Platform

Horizon Powering Germline and Somatic Multi-Omics

Modular by design. Horizon scales from population-level rare disease genomes to comprehensive precision tumor genomes.

Somatic mutation circos   chromosomal mutation landscape with structural-variant fusion links and a driver hotspot
Singularity

Horizon for Rare Disease

Singularity accelerates comprehensive SNV, Indel, and SV analysis, resolving the world's hardest cases through LLM-powered phenotype matching.

Explore module
Somatic mutation circos   chromosomal mutation landscape with structural-variant fusion links and a driver hotspot
Spectra

Horizon for Oncology

Including pan-cancer germline and somatic interpretation, Spectra module provides comprehensive tumor profiling to bring cancer therapeutic insights.

Explore module
Horizon Intelligence
Intelligence

Horizon Intelligence

Horizon Intelligence: Multi-agent AI, built for maximum impact to streamline diagnostics.

Explore module
Somatic mutation circos   chromosomal mutation landscape with structural-variant fusion links and a driver hotspot
Multimodal

Horizon Multimodal

Integrate transcriptomes, proteomes, and clinical phenotype data into one interpretation layer.

Explore module
Why Horizon

Built to make your lab efficient, fast and scalable

Three principles guide every layer of the platform and every capability we ship maps back to one of them.

Efficient

Clinical genomic guidelines and multi-omics data come together in one interpretation layer built for both rare disease and pan-cancer genomics.

Clinical genomic guidelines
Implemented for rare disease and pan-cancer genomics.
Multi-omics integration
Genomics and multi-omics inclusion along with phenotype integration.
Long-read compatible
Interprets long-read sequencing data for structural variants and complex regions.
96%Concordance with expert curation

Fast and Scalable

Optimized to run in minutes, not hours with the flexibility to scale from a single case to population-scale sequencing projects.

5-minute exome analysis
5 minutes for exome and 10 minutes variant tertiary analysis for long read whole genome sequencing.
CPU and GPU compatible
Runs on CPU and GPU infrastructure, from small to population-scale projects.
10K+Genomes processed at peak

Validated

Proven across real-world clinical cohorts from rare disease diagnosis to tumor profiling with therapeutic relevance.

Rare disease diagnostic yield
Demonstrated diagnosis yield in numerous cohorts, using short and long read genomes.
Validated tumor profiling
Tumor profiling with validated algorithms for therapeutic insights.
Long-read compatible
Diagnostic performance validated on long-read whole genome sequencing cohorts.
ValidatedAcross rare disease and oncology cohorts in peer review journals
End-to-End

From raw sequence to
actionable report

Step 01

Ingest

VCF, Pheno-intelligence Agent

Step 02

Process

QC filtering, variant annotation

Step 03

Interpret

ACMG/AMP classifications, ML implementation

Step 04

Report

Customizable report with evidence trail

0
Whole Genome
0
Exomes processed
0
Structural variants resolved
0
Countries
Client Experience with Horizon

Trusted by Researchers and Scientists

"As a scientist specializing in genomic variant interpretation, I find most platforms have steep learning curves and fragmented toolsets that require piecing together various algorithms and databases to identify disease-relevant variants. Horizon has completely transformed my workflow - its comprehensive suite of analysis tools integrated with expert-curated clinical variant databases enables me to go seamlessly to identify biologically significant and clinically actionable findings. Horizon's rapid, clinical capabilities make it my go-to platform for accelerating variant discovery and precision medicine insights."

NN
Dr. Nasna Nassir
Scientist, Center for Applied and Translational Genomics (CATG)

"Horizon is a powerful whole genome analytics platform which offers rapid analysis of both chromosomal microarray and whole genome sequencing data. It can identify and classify disease relevant variants within a short time as well as it provides the significant findings in a structured report. It is user friendly interface for which no bioinformatics expertise is required. As a user of Horizon, I wish for its immense success in recent precision medicine era."

HA
Dr. Hosneara Akter
Director, Neurogen Healthcare

"Horizon is one of the most reliable and user-friendly tools I’ve used, providing comprehensive annotation and ACMG codes for SNVs and structural variants. Its speed and efficiency, processing a whole genome in just 20–25 minutes, makes it my go-to tool for variant annotation and interpretation."

RN
Dr. Richa Naveed
Data Scientist, Center for Applied and Translational Genomics (CATG)

"Using Horizon has significantly streamlined my experience with clinical variant interpretation, supporting both small and structural variants. I particularly find its gene panel–based variant interpretation and comprehensive ACMG annotation very useful for assessing clinically relevant variants. The inclusion of pharmacogenetic information is an added advantage, providing valuable insights for personalized treatment and making Horizon a tool I rely on regularly."

DA
Dr. Dia Advani Jotwani
Postdoctoral Research Fellow, Center for Applied and Translational Genomics (CATG)
FAQ

Questions from
clinical teams

The answers scientific, laboratory and IT stakeholders ask us most before deploying Horizon.

Talk to our team

Horizon interprets the full range of variants from sequencing data, single nucleotide variants (SNVs), insertions and deletions (indels), copy number variants (CNVs), and structural variants (SVs).

Yes. Horizon applies established standards ACMG for germline classification and AMP for somatic variants so interpretation is consistent and guideline-based.

Yes. Horizon supports both short-read and long-read WGS data (i.e. Oxford Nanopore and PacBio HiFi). The platform supports long-read based SV interpretation as well.

Yes, Horizon integrates additional multi-omics data types together with genomic variants for a fuller picture. It can show gene expression from tissue specific single cell and proteomics dataset.

Horizon is built to enable clinical-grade standards to support diagnostic workflows. The platform has been validated through numerous clinical research cohorts to quantify diagnostic yield and to bring therapeutic insights.

Yes. Horizon connects to common LIMS and EHR systems through APIs, so it fits into your existing workflow rather than replacing it.

Data is enterprise scale encrypted in transit and at rest, with role-based access controls. Horizon can be deployed in the cloud or fully on-premise/in-region to meet your data-residency and privacy needs. Horizon is HIPAA compliant.

Horizon turns raw whole genome variants (from VCF) into a reviewed, report-ready list in 15 minutes, so your team spends less time on manual triage and deep dive projects at scale.

Get Started

Experience Horizon in your lab

Schedule a live walkthrough with our clinical scientists. See your own data interpreted in under an hour.

ACMG guided germline insights for germline variants (rare diseases)
Somatic AMP variant tiering and comprehensive tumor profiling.
Multi-omics integrated insights for diagnosis and therapeutics
Long-read WGS support for higher, validated diagnostic yield
Pharmacogenetic insights and live clinical trial database
Deploy on-prem, cloud or hybrid mode, maintaining data security
AI integrated, variant search, gene annotation, and auto reporting